Oxime Cross-Linked Biocompatible Polymer Hydrogels and Methods of Use Thereof
AssigneeThe Regents of the University of California
InventorsKaren Christman, Gregory Grover, Michael Madani, Masaki Fujita
Life of this patent
Estimating the term…
Abstract
Methods and hydrogels for preventing or reducing cellular adhesion and protein adsorption to a tissue (e.g. cardiac tissue) are disclosed. The hydrogels generally include at least two component polymers, a first polymer including an aminooxy group and a second polymer including a reactive oxo group, that are cross-linked by oxime bonds. The hydrogels are suitable for binding to and coating a tissue or cell. The hydrogels operate to reduce cellular adhesions and protein adsorption to the tissue or cell.
Claims20
An oxime cross-linked biocompatible hydrogel comprising:
- a first polymer comprising an aminooxy group selected from a hydroxyl amine and an alkoxy amine polymerized to a second polymer comprising a reactive oxo group,
- wherein the hydrogel has a surface comprising a surface oxo group that reversibly binds an amine group on a living tissue surface to form an imine.
A method of administering an oxime cross-linked bioadhesive hydrogel to a tissue for use as an in-situ anti-adhesion barrier comprising:
- administering to a living tissue of an individual an effective amount of a combination of a first polymer comprising an aminooxy group selected from a hydroxyl amine and an alkoxy amine, and a second polymer comprising a reactive oxo group,
- wherein the first polymer and second polymer are mixed and react to form an oxime cross-linked biocompatible hydrogel proximate to the tissue,
- wherein the hydrogel has a surface comprising a surface oxo group, and
- wherein the surface oxo group reversibly binds a surface amine on the tissue to form an imine.
Dependencies are inferred from the claim text.